164 related articles for article (PubMed ID: 21402070)
1. PU.1 is a major transcriptional activator of the tumour suppressor gene LIMD1.
Foxler DE; James V; Shelton SJ; Vallim TQ; Shaw PE; Sharp TV
FEBS Lett; 2011 Apr; 585(7):1089-96. PubMed ID: 21402070
[TBL] [Abstract][Full Text] [Related]
2. The chromosome 3p21.3-encoded gene, LIMD1, is a critical tumor suppressor involved in human lung cancer development.
Sharp TV; Al-Attar A; Foxler DE; Ding L; de A Vallim TQ; Zhang Y; Nijmeh HS; Webb TM; Nicholson AG; Zhang Q; Kraja A; Spendlove I; Osborne J; Mardis E; Longmore GD
Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19932-7. PubMed ID: 19060205
[TBL] [Abstract][Full Text] [Related]
3. LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p21.3, binds pRB and represses E2F-driven transcription.
Sharp TV; Munoz F; Bourboulia D; Presneau N; Darai E; Wang HW; Cannon M; Butcher DN; Nicholson AG; Klein G; Imreh S; Boshoff C
Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16531-6. PubMed ID: 15542589
[TBL] [Abstract][Full Text] [Related]
4. The hematopoietic cell-specific transcription factor PU.1 is critical for expression of CD11c.
Yashiro T; Kasakura K; Oda Y; Kitamura N; Inoue A; Nakamura S; Yokoyama H; Fukuyama K; Hara M; Ogawa H; Okumura K; Nishiyama M; Nishiyama C
Int Immunol; 2017 Feb; 29(2):87-94. PubMed ID: 28338898
[TBL] [Abstract][Full Text] [Related]
5. The +37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBPα, PU.1, and Additional Ets Factors.
Cooper S; Guo H; Friedman AD
PLoS One; 2015; 10(5):e0126385. PubMed ID: 25938608
[TBL] [Abstract][Full Text] [Related]
6. PU.1: a crucial and versatile player in hematopoiesis and leukemia.
Kastner P; Chan S
Int J Biochem Cell Biol; 2008; 40(1):22-7. PubMed ID: 17374502
[TBL] [Abstract][Full Text] [Related]
7. Dap12 expression in activated microglia from retinoschisin-deficient retina and its PU.1-dependent promoter regulation.
Weigelt K; Ernst W; Walczak Y; Ebert S; Loenhardt T; Klug M; Rehli M; Weber BH; Langmann T
J Leukoc Biol; 2007 Dec; 82(6):1564-74. PubMed ID: 17827340
[TBL] [Abstract][Full Text] [Related]
8. Vav1 and PU.1 are recruited to the CD11b promoter in APL-derived promyelocytes: role of Vav1 in modulating PU.1-containing complexes during ATRA-induced differentiation.
Brugnoli F; Lambertini E; Varin-Blank N; Piva R; Marchisio M; Grassilli S; Miscia S; Capitani S; Bertagnolo V
Exp Cell Res; 2010 Jan; 316(1):38-47. PubMed ID: 19747912
[TBL] [Abstract][Full Text] [Related]
9. SPI-C, a PU-box binding ETS protein expressed temporarily during B-cell development and in macrophages, contains an acidic transactivation domain located to the N-terminus.
Carlsson R; Persson C; Leanderson T
Mol Immunol; 2003 Jun; 39(16):1035-43. PubMed ID: 12749910
[TBL] [Abstract][Full Text] [Related]
10. Critical Role of Transcription Factor PU.1 in the Function of the OX40L/TNFSF4 Promoter in Dendritic Cells.
Yashiro T; Hara M; Ogawa H; Okumura K; Nishiyama C
Sci Rep; 2016 Oct; 6():34825. PubMed ID: 27708417
[TBL] [Abstract][Full Text] [Related]
11. PU.1 Suppresses Th2 Cytokine Expression via Silencing of GATA3 Transcription in Dendritic Cells.
Yashiro T; Kubo M; Ogawa H; Okumura K; Nishiyama C
PLoS One; 2015; 10(9):e0137699. PubMed ID: 26361334
[TBL] [Abstract][Full Text] [Related]
12. LIMD1 is more frequently altered than RB1 in head and neck squamous cell carcinoma: clinical and prognostic implications.
Ghosh S; Ghosh A; Maiti GP; Mukherjee N; Dutta S; Roy A; Roychoudhury S; Panda CK
Mol Cancer; 2010 Mar; 9():58. PubMed ID: 20226061
[TBL] [Abstract][Full Text] [Related]
13. Involvement of PU.1 in the transcriptional regulation of TNF-alpha.
Fukai T; Nishiyama C; Kanada S; Nakano N; Hara M; Tokura T; Ikeda S; Ogawa H; Okumura K
Biochem Biophys Res Commun; 2009 Oct; 388(1):102-6. PubMed ID: 19646961
[TBL] [Abstract][Full Text] [Related]
14. Pub, a novel PU.1 binding protein, regulates the transcriptional activity of PU.1.
Hirose S; Nishizumi H; Sakano H
Biochem Biophys Res Commun; 2003 Nov; 311(2):351-60. PubMed ID: 14592421
[TBL] [Abstract][Full Text] [Related]
15. Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells.
Kitamura N; Yokoyama H; Yashiro T; Nakano N; Nishiyama M; Kanada S; Fukai T; Hara M; Ikeda S; Ogawa H; Okumura K; Nishiyama C
J Allergy Clin Immunol; 2012 Mar; 129(3):814-824.e6. PubMed ID: 22112519
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide comparison of PU.1 and Spi-B binding sites in a mouse B lymphoma cell line.
Solomon LA; Li SK; Piskorz J; Xu LS; DeKoter RP
BMC Genomics; 2015 Feb; 16(1):76. PubMed ID: 25765478
[TBL] [Abstract][Full Text] [Related]
17. Critical Roles for PU.1, GATA1, and GATA2 in the expression of human FcεRI on mast cells: PU.1 and GATA1 transactivate FCER1A, and GATA2 transactivates FCER1A and MS4A2.
Inage E; Kasakura K; Yashiro T; Suzuki R; Baba Y; Nakano N; Hara M; Tanabe A; Oboki K; Matsumoto K; Saito H; Niyonsaba F; Ohtsuka Y; Ogawa H; Okumura K; Shimizu T; Nishiyama C
J Immunol; 2014 Apr; 192(8):3936-46. PubMed ID: 24639354
[TBL] [Abstract][Full Text] [Related]
18. Identification of a monopartite sequence in PU.1 essential for nuclear import, DNA-binding and transcription of myeloid-specific genes.
Kwok JC; Perdomo J; Chong BH
J Cell Biochem; 2007 Aug; 101(6):1456-74. PubMed ID: 17340619
[TBL] [Abstract][Full Text] [Related]
19. Involvement of PU.1 in NFATc1 promoter function in osteoclast development.
Ishiyama K; Yashiro T; Nakano N; Kasakura K; Miura R; Hara M; Kawai F; Maeda K; Tamura N; Okumura K; Ogawa H; Takasaki Y; Nishiyama C
Allergol Int; 2015 Jul; 64(3):241-7. PubMed ID: 26117255
[TBL] [Abstract][Full Text] [Related]
20. PU.1 and NFATc1 mediate osteoclastic induction of the mouse beta3 integrin promoter.
Crotti TN; Sharma SM; Fleming JD; Flannery MR; Ostrowski MC; Goldring SR; McHugh KP
J Cell Physiol; 2008 Jun; 215(3):636-44. PubMed ID: 18288635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
